Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Langley

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
The American Journal of Managed Care|June 6, 1997
Managed care guidelines for the economic evaluation of pharmaceuticalsP C Langley, R E Martin
Pharmacoeconomics|February 6, 1997
Peripheral vascular disorders. A pharmacoeconomic and quality-of-life reviewP C Langley, S J Coons
Business and Health|January 6, 2001
Can you measure the quality of this life? Interview by Lauren M. WalkerP C Langley, M A Testa
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 1, 1996
Disease management programsE P Armstrong, P C Langley
The American Journal of Managed Care|May 27, 1999
The cost effectiveness of patient-applied versus provider-administered intervention strategies for the treatment of external genital wartsP C Langley, S K Tyring, M H Smith
Clinical Therapeutics|January 25, 2000
Modeling the impact of treatment options in genital warts: patient-applied versus physician-administered therapiesP C Langley, G A Richwald, M H Smith
Clinical Therapeutics|April 2, 1998
A pharmacoeconomic assessment of enoxaparin and warfarin as prophylaxis for deep vein thrombosis in patients undergoing knee replacement surgeryD W Hawkins, P C Langley, K P Krueger
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 15, 1997
Pharmacoeconomic model of enoxaparin versus heparin for prevention of deep vein thrombosis after total hip replacementD W Hawkins, P C Langley, K P Krueger
Clinical Therapeutics|September 16, 1998
A review of cost-of-illness studies on obesityM A Kortt, P C Langley, E R Cox
Archives of Internal Medicine|December 9, 1996
Cost-effectiveness of regional poison control centersD L Harrison, J R Draugalis, M K Slack, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
The American Journal of Managed Care|June 6, 1997
Managed care guidelines for the economic evaluation of pharmaceuticalsP C Langley, R E Martin
Pharmacoeconomics|February 6, 1997
Peripheral vascular disorders. A pharmacoeconomic and quality-of-life reviewP C Langley, S J Coons
Business and Health|January 6, 2001
Can you measure the quality of this life? Interview by Lauren M. WalkerP C Langley, M A Testa
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 1, 1996
Disease management programsE P Armstrong, P C Langley
The American Journal of Managed Care|May 27, 1999
The cost effectiveness of patient-applied versus provider-administered intervention strategies for the treatment of external genital wartsP C Langley, S K Tyring, M H Smith
Clinical Therapeutics|January 25, 2000
Modeling the impact of treatment options in genital warts: patient-applied versus physician-administered therapiesP C Langley, G A Richwald, M H Smith
Clinical Therapeutics|April 2, 1998
A pharmacoeconomic assessment of enoxaparin and warfarin as prophylaxis for deep vein thrombosis in patients undergoing knee replacement surgeryD W Hawkins, P C Langley, K P Krueger
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 15, 1997
Pharmacoeconomic model of enoxaparin versus heparin for prevention of deep vein thrombosis after total hip replacementD W Hawkins, P C Langley, K P Krueger
Clinical Therapeutics|September 16, 1998
A review of cost-of-illness studies on obesityM A Kortt, P C Langley, E R Cox
Archives of Internal Medicine|December 9, 1996
Cost-effectiveness of regional poison control centersD L Harrison, J R Draugalis, M K Slack, et al.
Pageof 4